SynCo is capable of providing its customers with GMP stability studies to support our customers drug development programs, offering a considerable saving in sub-contractor project management. The stability studies can be provided for a range of different product stages, including pre-clinical, drug substance and drug product.

SynCo’s GMP stability testing capabilities include:

• ICH conditions
• Non ICH conditions
• Protocol generation
• Accelerated studies
• Degradation studies
• Appropriate analytical testing
• Final stability report

If you are interested in find out more about the stability services SynCo provides please contact us.